Baker Bros. Advisors’s Immune Design Corp. IMDZ Stock Holding History

Baker Bros. Advisors’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-148,937	Closed	-$491K	–	124
2018 Q1	$491K	Hold	148,937	–	–	﹤0.01%	111
2017 Q4	$581K	Hold	148,937	–	–	0.01%	113
2017 Q3	$1.54M	Hold	148,937	–	–	0.01%	101
2017 Q2	$1.45M	Hold	148,937	–	–	0.01%	94
2017 Q1	$1.01M	Hold	148,937	–	–	0.01%	101
2016 Q4	$819K	Hold	148,937	–	–	0.01%	113
2016 Q3	$1.13M	Hold	148,937	–	–	0.01%	108
2016 Q2	$1.22M	Hold	148,937	–	–	0.01%	112
2016 Q1	$1.94M	Hold	148,937	–	–	0.02%	102
2015 Q4	$2.99M	Hold	148,937	–	–	0.02%	93
2015 Q3	$1.82M	Hold	148,937	–	–	0.02%	106
2015 Q2	$3.08M	Buy	+148,937	New	+$3.52M	0.03%	92

Other funds holding IMDZ

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Baker Bros. Advisors's IMDZ Position: Q2 2018 in Review

Baker Bros. Advisors sold out of Immune Design Corp. (IMDZ) in Q2 2018, closing a stake of 148,937 shares — an estimated $491K sold.

Baker Bros. Advisors first reported a position in IMDZ in Q2 2015 and held it in 12 quarters. The position peaked at $3.08M in Q2 2015. 80 funds tracked by Wall St. Rank hold IMDZ as of Q2 2018.

Baker Bros. Advisors reported no remaining Immune Design Corp. position as of Q2 2018 after selling out during the quarter.
Baker Bros. Advisors sold 148,937 Immune Design Corp. shares in Q2 2018, an estimated $491K.
Baker Bros. Advisors first reported a position in Immune Design Corp. in Q2 2015 and held it in 12 quarters.
Baker Bros. Advisors's Immune Design Corp. position peaked at $3.08M in Q2 2015.
80 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2018.

Based on Baker Bros. Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.